A patient with pre-renal acute kidney injury is receiving an IV fluid bolus of normal saline. After administration, the patient becomes more confused and exhibits an increased respiratory rate of 26 breaths per minute. What is the nurse's priority action?

B) Stop the fluid infusion and assess for fluid overload and signs of heart failure.

A) Continue the fluid bolus to ensure adequate renal perfusion.

B) Stop the fluid infusion and assess for fluid overload and signs of heart failure.

C) Administer a diuretic to reduce fluid overload immediately.

D) Increase the rate of IV fluids to quickly correct the dehydration.

A patient with acute kidney injury (AKI) secondary to hypovolemia is receiving IV fluid therapy. Following initiation of fluids, the patient becomes confused and exhibits increased respiratory rate. Which nursing action is most appropriate to address these clinical changes?

B) Administer a prescribed diuretic to manage potential fluid overload

A) Increase the rate of IV fluid administration to improve renal perfusion

B) Administer a prescribed diuretic to manage potential fluid overload

C) Encourage oral fluid intake to supplement IV fluids

D) Discontinue all fluids immediately and notify the healthcare provider

A patient with acute heart failure exacerbation is being treated with furosemide to manage fluid overload. The nurse notices the patient's potassium level is 3.2 mEq/L. What is the most appropriate intervention by the nurse?

A) Administer potassium chloride as prescribed

B) Increase the rate of IV fluids to improve renal perfusion

C) Hold the furosemide and notify the healthcare provider

D) Continue monitoring and recheck the potassium level in 4 hours

A patient with heart failure and renal impairment is experiencing hypokalemia due to diuretic therapy. The clinical team plans to administer a potassium supplement and consider low-dose spironolactone. Which of the following nursing interventions is most critical to prioritize in this scenario?

C) Assess the patient's cardiac rhythm continuously via telemetry.

A) Monitor the patient's blood pressure closely for hypotension.

B) Educate the patient on the importance of maintaining fluid restriction.

C) Assess the patient's cardiac rhythm continuously via telemetry.

D) Monitor the patient's urine output for signs of oliguria.

A patient with heart failure exacerbation is receiving diuretic therapy and has developed hypokalemia with a serum potassium level of 3.2 mEq/L. The clinical team is considering interventions to prevent further complications. Which of the following nursing actions is most appropriate to implement first?

A) Administer potassium supplements as prescribed

B) Increase the frequency of blood pressure monitoring

C) Educate the patient about a low-sodium diet

D) Initiate a fluid restriction protocol

A patient with a recent onset of mild pulmonary edema is experiencing respiratory distress. The clinical team has reduced the IV fluid rate and initiated supplemental oxygen therapy. Which nursing intervention is most appropriate to prioritize in the next 24 hours to prevent further complications?

A) Monitor the patient's intake and output closely to assess fluid balance.

B) Administer a high-dose loop diuretic to rapidly reduce fluid overload.

C) Encourage the patient to increase fluid intake to improve kidney function.

D) Discontinue the low-dose spironolactone to prevent hyperkalemia.

A patient with a history of heart failure is exhibiting respiratory distress and has been diagnosed with mild pulmonary edema. The clinical team has reduced the rate of IV fluids and started supplemental oxygen therapy. Which nursing intervention is most appropriate to further address the patient's respiratory status?

B) Position the patient in a high Fowler's position.

A) Encourage the patient to perform incentive spirometry every hour.

B) Position the patient in a high Fowler's position.

C) Instruct the patient to restrict fluid intake to 1 liter per day.

D) Administer antitussive medication to reduce coughing.

A patient undergoing treatment with loop diuretics presents with mild hypokalemia and borderline low blood pressure. Which nursing intervention should be prioritized to address the patient's condition and prevent complications?

B) Administer prescribed potassium supplements and monitor electrolyte levels closely.

A) Increase the dosage of loop diuretics to enhance renal function.

B) Administer prescribed potassium supplements and monitor electrolyte levels closely.

C) Encourage the patient to increase oral fluid intake to counteract hypotension.

D) Discontinue supplemental oxygen therapy to prevent oxygen toxicity.

A patient being treated with loop diuretics for fluid overload shows improvement in respiratory status but develops mild hypokalemia with a serum potassium level of 3.2 mEq/L. The healthcare team decides to administer potassium supplements. Which additional intervention should the nurse anticipate to prevent complications associated with hypokalemia?

B) Initiate telemetry monitoring

A) Decrease the patient's diuretic dosage

B) Initiate telemetry monitoring

C) Increase the patient's oral fluid intake

D) Administer magnesium supplements

PRE RENAL AKI - Nursing Case Study

Pathophysiology

• Primary mechanism: Decreased renal perfusion leads to reduced glomerular filtration rate (GFR), primarily due to hypovolemia, heart failure, or renal artery stenosis. This reduced blood flow results in decreased oxygen delivery and nutrient supply to the kidneys, impairing their function.

• Secondary mechanism: Activation of the renin-angiotensin-aldosterone system (RAAS) occurs as a compensatory response to low blood volume, leading to vasoconstriction and sodium retention, which can exacerbate the reduction in renal perfusion and worsen kidney function if prolonged.

• Key complication: If uncorrected, persistent low renal perfusion can lead to ischemic damage to the renal parenchyma, potentially progressing to intrinsic renal injury, complicating recovery and potentially leading to chronic kidney disease.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus

• Current medications: Lisinopril, Metformin, Hydrochlorothiazide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and fatigue

• Key symptoms: Thirst, dizziness, mild confusion, dry mucous membranes

• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 96% on room air

Section 1

As the initial assessment continues, the nurse notes that the patient’s skin turgor is poor, indicating significant dehydration, which correlates with his complaint of thirst and the dry mucous membranes observed. An orthostatic blood pressure measurement reveals a further drop to 85/55 mmHg when the patient is moved from a supine to a standing position, with an increase in heart rate to 120 bpm, reinforcing the suspicion of hypovolemia as a primary contributor to the pre-renal acute kidney injury (AKI). The patient’s urine output remains low at 15 mL/hr, further supporting the diagnosis of decreased renal perfusion.

Laboratory tests are ordered to evaluate kidney function and electrolyte balance. The results show an elevated blood urea nitrogen (BUN) level of 35 mg/dL and serum creatinine of 2.2 mg/dL, consistent with acute kidney injury. The BUN to creatinine ratio is increased, suggesting a pre-renal etiology. Serum electrolytes reveal mild hyperkalemia at 5.5 mEq/L and hyponatremia at 130 mEq/L, indicating potential complications if not addressed promptly. Metabolic acidosis is noted with a bicarbonate level of 18 mEq/L, which could worsen if the underlying issue is not rectified.

The clinical team initiates an IV fluid bolus of normal saline to address the hypovolemia and improve renal perfusion. However, as fluids are administered, the patient’s mental status becomes more confused, and his respiratory rate increases to 26 breaths per minute. This change in status prompts a reassessment of the patient's cardiac function, raising concerns about possible heart failure exacerbation as a complicating factor due to fluid overload. The clinical team must now balance fluid resuscitation with careful monitoring for signs of fluid overload, utilizing diuretics if necessary, and consider a nephrology consultation to adjust the management plan accordingly.

Section 2

As the clinical team continues to monitor the patient, new diagnostic results reveal an elevated BNP level of 550 pg/mL, supporting the suspicion of heart failure exacerbation. A chest X-ray demonstrates pulmonary congestion and mild cardiomegaly, indicating fluid overload has started to impact cardiac function. The patient's jugular venous pressure is noted to be elevated upon physical examination, further corroborating the findings of fluid overload contributing to the worsening respiratory status.

In response to these developments, the clinical team decides to adjust the treatment plan. They initiate a low-dose diuretic therapy with furosemide to help alleviate the fluid overload while cautiously continuing IV fluid therapy at a reduced rate to maintain renal perfusion. The patient's electrolyte levels are closely monitored, particularly the potassium level, given the risk of diuretic-induced hypokalemia exacerbating the existing mild hyperkalemia. The patient's mental status and respiratory rate are closely observed for improvement or further deterioration.

Despite initial concerns, the patient's respiratory rate gradually decreases to 20 breaths per minute, and his mental status shows signs of stabilization as the diuretic begins to reduce fluid overload. The urine output increases to 30 mL/hr, suggesting an improvement in renal perfusion. This positive response indicates that the balance between managing fluid overload and ensuring adequate renal perfusion is being achieved. However, the clinical team remains vigilant, recognizing that the patient is still at risk for electrolyte imbalances and further renal impairment. A nephrology consult is planned to provide expert guidance on continued management, ensuring the patient's recovery trajectory remains on course.

Section 3

As the clinical team continues to monitor the patient, new complications arise that demand further clinical reasoning and adjustment of the treatment plan. Over the next 24 hours, the patient's electrolyte panel reveals a serum potassium level that has dropped to 3.2 mEq/L, indicating hypokalemia likely induced by the diuretic therapy. This change in potassium level poses a risk for arrhythmias, given the patient's concurrent heart failure exacerbation. Additionally, the patient's serum creatinine level is noted to have increased slightly to 2.4 mg/dL, suggesting that while renal perfusion has initially improved, there is still potential for ongoing renal impairment if not carefully managed.

In response to these findings, the clinical team decides to administer a potassium supplement to address the hypokalemia, while continuing to monitor cardiac rhythms closely through telemetry. The rate of IV fluid therapy is reassessed to ensure it supports renal function without contributing to fluid overload. Additionally, the nephrology consult provides input on optimizing the balance of fluid management and renal protection, suggesting the potential use of low-dose spironolactone to assist with potassium conservation and further mitigate fluid overload.

Despite the complexity of managing these intertwined issues, the patient shows signs of stabilization. His blood pressure is maintained within a normal range at 125/78 mmHg, and his heart rate remains steady at 82 beats per minute. The clinical team remains vigilant, recognizing that the patient's condition is delicate and requires ongoing adjustment of interventions to prevent further complications. Regular assessment of his electrolyte levels and renal function, along with attentive monitoring of his cardiac status, will be crucial in navigating this critical phase of the patient's recovery. The team prepares for continued monitoring and potential adjustments as they aim to guide the patient towards a more stable condition.

Section 4

Over the next 12 hours, the patient begins to exhibit signs of respiratory distress, with an increasing respiratory rate of 24 breaths per minute and an oxygen saturation level that has decreased to 90% on room air. Auscultation reveals crackles in the lung bases, suggesting the potential onset of pulmonary congestion secondary to fluid shifts or exacerbation of heart failure. The clinical team promptly reassesses the patient's fluid status and conducts a chest X-ray, which confirms mild pulmonary edema. This new complication necessitates immediate clinical reasoning to adjust the treatment strategy.

In response to these developments, the clinical team decides to reduce the rate of IV fluid administration, balancing the need to maintain renal perfusion while preventing further fluid overload. Additionally, they initiate supplemental oxygen therapy to maintain adequate oxygenation and closely monitor the patient's respiratory status. The nephrology team recommends a reevaluation of diuretic therapy, considering the addition of a low-dose loop diuretic to further address fluid retention while continuing the low-dose spironolactone for potassium conservation.

The next 24 hours are critical as the team strives to stabilize the patient's condition and prevent further complications. Continuous monitoring of vital signs, electrolyte levels, and renal function is prioritized, with adjustments to the treatment plan made as necessary based on the patient's evolving status. The collaborative approach of the clinical team aims to guide the patient through this acute phase, focusing on optimizing both cardiac and renal function while mitigating the risks associated with fluid overload and electrolyte imbalances.

Section 5

As the next 24 hours progress, the patient's response to the adjusted treatment plan becomes a focal point for the clinical team. Initially, the reduction in IV fluid administration and the introduction of low-dose loop diuretics produce a notable improvement in the patient's respiratory status. The respiratory rate decreases to 20 breaths per minute, and oxygen saturation levels stabilize at 95% with supplemental oxygen. However, the team remains vigilant, aware that the risk of electrolyte imbalance is heightened due to the diuretic therapy.

Lab results reveal a mild hypokalemia, with serum potassium levels decreasing to 3.2 mEq/L. This finding necessitates a prompt adjustment to the treatment regimen to prevent potential complications such as cardiac arrhythmias. The team decides to administer potassium supplements and continues monitoring electrolyte levels closely. Additionally, the patient's renal function shows slight improvement, with serum creatinine levels decreasing from 2.1 mg/dL to 1.8 mg/dL, indicating better renal perfusion and filtration.

Despite these positive signs, the patient's blood pressure remains borderline low, with readings fluctuating between 98/60 mmHg and 105/65 mmHg. This hypotensive trend prompts further clinical reasoning to ensure that the delicate balance between fluid management and renal perfusion is maintained. The team considers adjusting the diuretic dosage while closely watching for signs of decreased renal output or worsening cardiac function. This collaborative effort aims to stabilize the patient further, anticipating the next steps in the recovery process while preventing new complications from arising.